People who had one jab after having COVID-19 now included in vaccination coverage figures for full vaccination Vaccination coverage in the Netherlands rose more sharply this week than in previous weeks, increasing to 81.7% among people aged 18 years and older and 79.0% among those aged 12 years and older.
Vaccination figures now available by municipality RIVM is providing access to COVID-19 vaccination figures by municipality via open data as of today. The open data now includes vaccination turnout and coverage by municipality for three age groups.
More attention needed for mental health refugees Although the physical health of asylum seekers holding a temporary residence permit (permit holders) is relatively good, this is to a much lesser extent the case with respect to mental health.
New international project Inno4Vac targets faster vaccine development Inno4vac, a new European interdisciplinary project was launched on 1 September. Inno4vac focuses on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of new vaccines.
Dust in IJmond contains many PAHs and metals In Wijk aan Zee, Beverwijk, Velsen-Noord and IJmuiden, more polycyclic aromatic hydrocarbons (PAHs) and metals were found in the deposition of dust than outside the IJmond region.
Number of STIs continues to rise at Dutch STI clinics In the first half of this year more STIs were found in people who have been tested at Dutch STI clinics. The increase pertains to all STIs, with the exception of HIV.
European Antibiotic Awareness Day 2016 Friday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe attention focuses on the threat of antibiotic resistance to people and animals.
EU legislation genetically modified microbial biocontrol agents is fit for purpose EU legislative instruments are sufficient to ensure the safety of such products.
Surveillance and developments National Immunisation Programme 2015-2016 The report provides an overview of effectiveness and safety of vaccines and vaccine research.
RIVM starts field research into rubber granulate RIVM has started to take samples of rubber granulate from 100 synthetic turf fields in the Netherlands.